|
Volumn 100, Issue 3, 2002, Pages 158-163
|
Diabetic nephropathy - Prevention and treatment
|
Author keywords
ACE inhibitors; Advanced glycosylation end products; Aldose reductase inhibitors; Antilipidaemic agents; Blood pressure; Calcium channel blockers; Diabetic nephropathy; Renal replacement therapy
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
ALDOSE REDUCTASE INHIBITOR;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ARTICLE;
BLOOD GLUCOSE MONITORING;
BLOOD PRESSURE REGULATION;
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS;
DIABETIC NEPHROPATHY;
DYSLIPIDEMIA;
HEMODIALYSIS;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
KIDNEY FAILURE;
KIDNEY TRANSPLANTATION;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS TRANSPLANTATION;
PROTEIN INTAKE;
ADULT;
AGED;
CHRONIC KIDNEY FAILURE;
FEMALE;
HOSPITALIZATION;
INCIDENCE;
INDIA;
KIDNEY FUNCTION TEST;
MALE;
METHODOLOGY;
MIDDLE AGED;
PRIMARY PREVENTION;
PROGNOSIS;
RENAL REPLACEMENT THERAPY;
REVIEW;
RISK ASSESSMENT;
RISK FACTOR;
SURVIVAL RATE;
ADULT;
AGED;
DIABETIC NEPHROPATHIES;
FEMALE;
HUMANS;
INCIDENCE;
INDIA;
KIDNEY FAILURE, CHRONIC;
KIDNEY FUNCTION TESTS;
MALE;
MIDDLE AGED;
PRIMARY PREVENTION;
PROGNOSIS;
RENAL DIALYSIS;
RISK ASSESSMENT;
RISK FACTORS;
SEVERITY OF ILLNESS INDEX;
SURVIVAL RATE;
|
EID: 0036321844
PISSN: 00195847
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (7)
|